Daktronics amended its JPMorgan Credit agreement to permit transfers of certain non-material patents for consideration below 75% of fair market value. The change matters to investors because it creates contractual permission for the specified Patent transfer under the Acquisition documents while leaving the agreement’s other stated framework in place.
Key Highlights
- Daktronics’ original credit agreement was dated November 26, 2025.
- Amendment No. 1 permits Daktronics to transfer certain non-material patents under the acquisition documents.
- Consideration for the patent transfer is set below 75% of fair market value.
Daktronics, Inc. (NASDAQ: DAKT) amended its credit agreement with JPMorgan Chase Bank, N.A. acting as agent, to allow the transfer of certain non-material patents for consideration below 75% of fair market value. The change was made through Amendment No. 1 to the credit agreement. The amendment covers the company, the lenders and the other Loan parties.
JPMorgan Agreement Opens Patent Transfer
Amendment No. 1 modifies the credit agreement dated November 26, 2025. The amendment specifically permits Daktronics to transfer certain non-material patents. The permission applies to the terms and conditions set out in the acquisition documents.
Consideration Set Below Fair Value
The amendment therefore establishes the pricing condition attached to the patent transfer. The agreement change relates to those patents and does not describe a broader transfer of assets.
Terms Governed by Acquisition Documents
Amendment No. 1 provides the contractual permission for the specified transaction under Daktronics’ credit agreement. The amendment became effective September 1, 2026.
Peers Moving on This News
- Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) little changed
- LightPath Technologies, Inc. (NASDAQ: LPTH) down 0.6%
- Aeva Technologies, Inc. (NASDAQ: AEVA) down 0.9%
FAQs
Q: What does Amendment No. 1 permit Daktronics to do?
A: Amendment No. 1 permits Daktronics to transfer certain non-material patents under the terms and conditions in the acquisition documents. The consideration is set below 75% of fair market value.
Q: When did the amendment become effective?
A: The amendment became effective September 1, 2026. It modifies the credit agreement dated November 26, 2025, involving Daktronics, the lenders and other loan parties.
Q: What role does JPMorgan Chase Bank, N.A. have?
A: JPMorgan Chase Bank, N.A. acts as agent under the credit agreement. The amendment provides contractual permission for the specified patent transaction and does not describe a broader asset transfer.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.